Clinical Trial Update: Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Lower Limb Spasticity [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on MYOBLOC for adult lower limb spasticity, spanning Phase 2 and Phase 3 to evaluate efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spasticity

Drugs mentioned

• MYOBLOC (rimabotulinumtoxinB)

Snippet

Sponsor: Supernus Pharmaceuticals, Inc. | Conditions: Spasticity | Phase 2, Phase 3 | Status: UNKNOWN